--- title: "(NU/1257) Clinical Trail Unit or Contracted Research Organisation to Set up and Manage Vision DMD Phase 2b and extension study" ocid: "ocds-b5fd17-7040fb67-896b-40fb-9da7-deafc7925355" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-7040fb67-896b-40fb-9da7-deafc7925355" markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-7040fb67-896b-40fb-9da7-deafc7925355.md" json_url: "https://d3tenders.com/contract/ocds-b5fd17-7040fb67-896b-40fb-9da7-deafc7925355.json" source: "Contracts Finder" current_stage: "Award" buyer: "NEWCASTLE UNIVERSITY" published: "2018-01-16" --- # (NU/1257) Clinical Trail Unit or Contracted Research Organisation to Set up and Manage Vision DMD Phase 2b and extension study Buyer: NEWCASTLE UNIVERSITY Current stage: Award OCID: ocds-b5fd17-7040fb67-896b-40fb-9da7-deafc7925355 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-7040fb67-896b-40fb-9da7-deafc7925355) [Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-7040fb67-896b-40fb-9da7-deafc7925355.json) ## Summary The public procurement process involves Newcastle University, which seeks a Clinical Trial Unit (CTU) or Contracted Research Organisation (CRO) to set up and manage a clinical study titled "(NU/1257) Clinical Trial Unit or Contracted Research Organisation to Set up and Manage Vision DMD Phase 2b and extension study." This procurement falls within the research and development services industry category, specifically aimed at conducting a double-blind, placebo-controlled study for Duchenne Muscular Dystrophy. The procurement method is classified as an open procedure, and the contract is set to commence following the award, which took place on 19 December 2017, and will run until 31 May 2021, with a total contract value of £1,139,000, covering multiple geographical lots including the UK, Australia, Israel, and Sweden. This tender presents significant growth opportunities for businesses specialising in clinical trial management, research services, and medical consultancy. Organisations experienced in conducting clinical trials, particularly those with a presence or capability in the UK, Australia, Israel, or Sweden, would be well-positioned to compete. The contract's collaborative nature with Newcastle University and the potential involvement of other healthcare-related entities makes it an attractive opportunity for both small and large enterprises active in the clinical research sector. ## Notice The scope of this contract relates specifically to the Phase 2b Randomized, Double-blind, Parallel Placebo- and Active-controlled Study to Assess the Efficacy and Safety of Vamorolone in Ambulatory Boys with Duchenne Muscular Dystrophy (DMD) and the extension study that will follow this. A registered Clinical Trial Unit (CTU) or Contracted Research Organisation (CRO) is required to set up and manage the clinical trial at sites in [UK/Australia/Israel/Sweden]. The CTU / CRO will be carrying out delegated duties on behalf of the sponsor, ReveraGen, but will be receiving payments for these duties from the Vision-DMD Horizon 2020 grant, coordinated by Newcastle University. The contract will begin on award and end in November 2019 and be followed by an extenstion study. This contract consists of 4 separate geographical Lots: Lot 1: UK Lot 2: Australia Lot 3: Israel Lot 4: Sweden ## Key Details | Field | Value | | --- | --- | | Publication source | Contracts Finder | | Latest notice | https://www.contractsfinder.service.gov.uk/Notice/dc35d72f-9d17-4eb7-bbcc-e1a972aaeebb | | Notice type | Award Notice | | Procurement type | Standard | | Procurement category | Services | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Large, SME | | All stages | Award | ## Dates | Field | Value | | --- | --- | | Publication date | 16 Jan 2018 | | Submission deadline | 31 Mar 2017 | | Future notice date | Not specified | | Award date | 19 Dec 2017 | | Contract period | 3 Jan 2018 - 31 May 2021 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £1,000,000 | | Lots value | Not specified | | Awards value | £1,139,000 | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Not specified | | Awards status | Active | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | NEWCASTLE UNIVERSITY | | Locality | NEWCASTLE UPON TYNE | | Post town | Newcastle upon Tyne | | Postcode | NE1 7RU | | Country | England | | ITL 1 | TLC North East (England) | | ITL 2 | TLC4 Northumberland, Durham and Tyne & Wear | | ITL 3 | TLC43 Tyneside | | Local authority | Newcastle upon Tyne | | Electoral ward | Monument | | Westminster constituency | Newcastle upon Tyne Central and West | | Delivery location | TLC North East (England) | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 4 | | Supplier names | GOTHIA FORUM FOR CLINICAL RESEARCH; NOVOTECH; PSR GROUP B V; TCA CLINICAL RESEARCH | ## CPV Codes ### Divisions - 73 - Research and development services and related consultancy services ### Codes - 73000000 - Research and development services and related consultancy services ## Release History - 16 Jan 2018 at 16:12 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/dc35d72f-9d17-4eb7-bbcc-e1a972aaeebb ## Documents - https://www.contractsfinder.service.gov.uk/Notice/dc35d72f-9d17-4eb7-bbcc-e1a972aaeebb 16th January 2018 - Awarded contract notice on Contracts Finder - https://procontract.due-north.com/Advert?advertId=e6691902-a0f3-e611-80dd-005056b64545 Advert ## Notice URLs - https://www.ncl.ac.uk ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-7040fb67-896b-40fb-9da7-deafc7925355. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-7040fb67-896b-40fb-9da7-deafc7925355.json.